Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00369421 · ClinicalTrials.gov registry record
Diagnosis and Treatment of Patients With Inborn Errors of Metabolism
A clinical trial of Arterial Calcification Due to Deficiency of CD73, sponsored by National Human Genome Research Institute (NHGRI).
- Recruiting
- Registry status
- 4,000
- Enrollment target
- 1
- Study location
NCT00369421 is a study of Arterial Calcification Due to Deficiency of CD73 that is actively recruiting participants, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 4,000 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00369421, a study of Arterial Calcification Due to Deficiency of CD73, is actively recruiting participants, sponsored by National Human Genome Research Institute (NHGRI).
- RECRUITING
- Registry status
- 4,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Researchers intend on diagnosing and treating certain inborn errors of metabolism. By doing this researchers hope to expand their knowledge about these disorders and provide access to patients of interest for research, teaching, and clinical experience. Patients participating in this study will be examined and treated on an out patient basis, if practical. However, patients requiring specialized tests or treatments will be admitted to the NIH Clinical Center as necessary. Researchers will use only accepted medical procedures in diagnosing (medical history, physical examinations, X-ray studies, eye examinations, blood tests, and urine tests) and treating the patients involved in this study. Additional tests may be required on a case to case basis. Many patients seen in this study will go on to be enrolled in a specific disease-related research study.\<TAB\>
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 1978-09-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00369421
The ClinicalTrials.gov registry entry for NCT00369421 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 4,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Human Genome Research Institute (NHGRI), which has 185 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Arterial Calcification Due to Deficiency of CD73 appearing as the primary indexed condition, and to 0 interventions.
NCT00369421 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00369421 about?
NCT00369421 is a clinical study titled "Diagnosis and Treatment of Patients With Inborn Errors of Metabolism". Researchers intend on diagnosing and treating certain inborn errors of metabolism. By doing this researchers hope to expand their knowledge about these disorders and provide access to patients of interest for research, teaching, and clinical experience. Patients participating in this study will be ...
What is the current status of trial NCT00369421?
This trial is currently recruiting. The enrollment target is 4,000 participants. The study started on 1978-09-12.
What conditions does trial NCT00369421 study?
This clinical trial studies the following conditions: Arterial Calcification Due to Deficiency of CD73.
Who is sponsoring clinical trial NCT00369421?
This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00369421 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.